106190 — High Tech Pharm Co Income Statement

0.000.00%

Last trade - 00:00

HealthcareAdventurousSmall CapNeutral

Annual income statement for High Tech Pharm Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	73,287	102,947	76,772	77,513	70,183
Cost of Revenue
Gross Profit	3,078	7,779	12,843	19,487	16,944
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Unusual Expense / Income
Total Operating Expenses	73,699	98,020	66,683	61,955	57,327
Operating Profit	-412	4,927	10,089	15,558	12,856
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	-868	4,028	9,864	17,087	13,828
Provision for Income Taxes
Net Income After Taxes	-1,225	5,873	8,076	13,710	11,475
Net Income Before Extraordinary Items
Net Income	-1,225	5,873	8,076	13,710	11,475
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	-1,225	5,873	8,076	13,710	11,475
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	-115	544	755	1,283	1,065
Dividends per Share